Results 211 to 220 of about 340,047 (304)

Editorial: Retinitis pigmentosa, macular degeneration and related diseases. [PDF]

Front Cell Neurosci
Weiss ER, Han Z.
europepmc   +1 more source

Surface Glare Suppression in Retinal Imaging With a Cross‐Polarized Line‐Scanning Color Fundus Camera

Journal of Biophotonics, Volume 19, Issue 11, November 2026.
A line‐scanning color fundus camera combines line‐confocal gating and cross‐polarization to suppress corneal and optical surface glare. Broadband white‐light illumination enables true‐color retinal imaging without pupil dilation across an approximately 60° horizontal field of view, using a compact, relatively low‐cost design. ABSTRACT Fundus imaging is
Xingyu Yang, Zijian Zhang, Xiuju Chen, Philip I. Burgess, Sarah McGhee, Mark Johnson, Ticiana Criddle, Gabriela Czanner, Simon P. Harding, David Wong, Xiaoxin Li, Yalin Zheng, Yaochun Shen   +12 more
wiley   +1 more source

First‐in‐Human Regulatory T Cell‐Derived Exosomes Plus Ranibizumab for Refractory nAMD

Journal of Extracellular Vesicles, Volume 15, Issue 11, November 2026.
ABSTRACT Persistent fluid despite intravitreal anti–vascular endothelial growth factor (VEGF) treatment remains common in neovascular age‐related macular degeneration (nAMD). Regulatory T cell–derived exosomes (TregExo) have preclinical immunomodulatory activity. To evaluate the safety and maximum tolerated dose (MTD) of intravitreal autologous TregExo
Ying Tian, Zhuyun Qian, Shuzhen Fan, Jianmin Wang, Wei Wei, Yong Tao   +5 more
wiley   +1 more source

What Should Patients With Age-Related Macular Degeneration Eat? [PDF]

Am J Ophthalmol
Keenan TDL, Hébert M, Chew EY, Johnson MW.   +3 more
europepmc   +1 more source

Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms

Journal of Inherited Metabolic Disease, Volume 49, Issue 6, November 2026.
ABSTRACT Nucleic acid therapeutics (NATs), including antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), messenger RNA (mRNA) therapeutics and programmable editing technologies, are reshaping the therapeutic landscape for inherited metabolic and genetic disease.
Tomasz Z. Tomkiewicz, Siyamini Sivananthan, Paul Gissen, Haiyan Zhou   +3 more
wiley   +1 more source

Prevalence, Associations, and Visual Impact of Myopic Macular Degeneration in a Multi-ethnic Older Population in Singapore: The PIONEER Study. [PDF]

Ophthalmol Ther
Cheong KX, Wu F, Hoang QV, Lai JS, Zhang Y, Htoon HM, Ohno-Matsui K, Lamoureux EL, Saw SM, Gupta P.   +9 more
europepmc   +1 more source

Macrophages and macular degeneration.

Journal of ophthalmic & vision research, 2014
openaire   +2 more sources

Targeted Protein Degradation: From Molecular Mechanisms to Emerging Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Graphical overview of targeted protein degradation: mechanisms, molecular determinants, delivery strategies, and therapeutic development. This graphical abstract summarizes the major degradation pathways involved in targeted protein degradation, including the ubiquitin–proteasome system, endocytosis–lysosome pathway, and autophagy‐dependent degradation.
Huaijuan Guo, Haishuang Duan, Yang Liu, Kelan Fang, Lujia Xiao, Ling Bai, Xiao Qu, Xuebing Yan, Kun Zhang   +8 more
wiley   +1 more source